Keppra XR is the brand name used in the United States, Canada, the UK, Australia, and some other countries for levetiracetam.

The United States Food and Drug Administration (FDA) approved Keppra XR in 2008 for adjunctive therapy for partial-onset seizures in adult patients with epilepsy.

Forms
Keppra XR is marketed in the United States by UCB Pharma, Inc. These descriptions apply to the U.S. versions:

Tablets

	500-mg (white, film-coated tablet, imprinted with "UCB 500XR in red on one side)
	750-mg (white, film-coated tablet, imprinted with "UCB 750XR in red on one side)

Keppra XR is not available in generic formulations.

How to take and store Keppra XR
Keppra XR can be taken with or without food.

Keppra XR tablets must be swallowed whole. They should not be chewed, broken, or crushed.

Keppra XR should be stored at room temperature, away from humidity and light.

Missed doses
In general, tell patients that if they forget a dose, they should take it as soon as they remember. If it is almost time for the next dose, instruct them on whether they should delay that dose for a period of hours instead of taking two doses very close together.

Patients who often forget doses may benefit from using a special pillbox or watch with an alarm.